World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
110
Citations
40603
World Ranking
5603
National Ranking
162

Jean Sibilia publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Jean Sibilia sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 715 publications — 82nd percentile

82% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Jean Sibilia D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Jean Sibilia sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 110 D-Index — 73rd percentile

73% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Jean Sibilia is affiliated with the University of Strasbourg in France, contributing extensively to the field of medicine with a particular focus on rheumatology, immunology, infectious diseases, pathology and forensic medicine, and genetics. Their work includes 344 publications in medicine, with specific attention to several subfields.

Their primary areas of research cover topics such as systemic lupus erythematosus, rheumatoid arthritis, systemic sclerosis and related diseases, inflammatory myopathies and dermatomyositis, as well as SARS-CoV-2 and COVID-19 research, including various clinical studies on COVID-19. These topics are supported by a body of work spanning dozens of publications in each domain.

Jean Sibilia has published numerous papers in notable scientific venues. Among the most frequent publication outlets are:

  • Revue du Rhumatisme
  • Annals of the Rheumatic Diseases
  • Lara D. Veeken
  • La Revue de Médecine Interne
  • bioRxiv (Cold Spring Harbor Laboratory)

Their recent papers illustrate the scope of their research interests and contributions:

  • "Intrafamilial Exposure to SARS-CoV-2 Associated with Cellular Immune Response without Seroconversion, France" (2020), published in Emerging infectious diseases
  • "Long-Term Rituximab Use to Maintain Remission of Antineutrophil Cytoplasmic Antibody-Associated Vasculitis" (2020), published in Annals of Internal Medicine
  • "Worldwide trends in all-cause mortality of auto-immune systemic diseases between 2001 and 2014" (2020), published in Autoimmunity Reviews
  • "Vaccination against COVID-19: Expectations and concerns of patients with autoimmune and rheumatic diseases" (2021), published in The Lancet Rheumatology
  • "Identification of driver genes for critical forms of COVID-19 in a deeply phenotyped young patient cohort" (2021), published in Science Translational Medicine

Jean Sibilia collaborates frequently with a select group of coauthors, reflecting interdisciplinary work and shared expertise. These frequent coauthors include:

  • Renaud Felten
  • Laurent Arnaud
  • Marc Scherlinger
  • Thierry Martin
  • Emmanuel Chatelus

Best Publications

  • Early detection of pulmonary arterial hypertension in systemic sclerosis: a French nationwide prospective multicenter study.

    Eric Hachulla;Virginie Gressin;Loïc Guillevin;Patrick Carpentier

  • Activation of IFN pathways and plasmacytoid dendritic cell recruitment in target organs of primary Sjögren’s syndrome

    Jacques-Eric Gottenberg;Nicolas Cagnard;Carlo Lucchesi;Franck Letourneur

  • Anticitrullinated protein/peptide antibody assays in early rheumatoid arthritis for predicting five year radiographic damage

    O Meyer;C Labarre;M Dougados;Ph Goupille

  • Treatment of rheumatoid arthritis with the selective costimulation modulator abatacept - Twelve-month results of a phase IIb, double-blind, randomized, placebo-controlled trial

    Joel J.M. Kremer;Maxime Dougados;Paul Emery;Patrick Durez

  • Incidence and Prevalence of Systemic Sclerosis: A Systematic Literature Review

    Hélène Chifflot;Bruno Fautrel;Christelle Sordet;Emmanuel Chatelus

  • Inefficacy of infliximab in primary Sjögren's syndrome: results of the randomized, controlled Trial of Remicade in Primary Sjögren's Syndrome (TRIPSS).

    Xavier Mariette;Philippe Ravaud;Serge Steinfeld;Gabriel Baron

  • Women, men, and rheumatoid arthritis: analyses of disease activity, disease characteristics and treatments in the QUEST-RA study

    Tuulikki Sokka;Sergio Toloza;Maurizio Cutolo;Hannu Kautiainen

  • Tolerance and short-term efficacy of rituximab in 43 patients with systemic autoimmune diseases

    JE Gottenberg;L Guillevin;O Lambotte;B Combe

  • Treatment of Primary Sjögren Syndrome With Rituximab: A Randomized Trial

    Valérie Devauchelle-Pensec;Xavier Mariette;Sandrine Jousse-Joulin;Jean-Marie Berthelot

  • Lymphomas in rheumatoid arthritis patients treated with methotrexate: a 3-year prospective study in France

    Xavier Mariette;Dominique Cazals-Hatem;Josiane Warszawki;Frédéric Liote

  • MUC5B Promoter Variant and Rheumatoid Arthritis with Interstitial Lung Disease.

    Pierre-Antoine Juge;Joyce S Lee;Esther Ebstein;Hiroshi Furukawa

  • Safety and efficacy of rituximab in systemic lupus erythematosus: Results from 136 patients from the French autoimmunity and rituximab registry

    Benjamin Terrier;Zahir Amoura;Philippe Ravaud;Eric Hachulla

  • Efficacy of etanercept for the treatment of juvenile idiopathic arthritis according to the onset type

    Pierre Quartier;Pierre Taupin;Franck Bourdeaut;Irène Lemelle

  • Interleukin-1 receptor antagonist (anakinra) treatment in patients with systemic-onset juvenile idiopathic arthritis or adult onset Still disease: preliminary experience in France

    T Lequerré;P Quartier;D Rosellini;F Alaoui

  • Systemic lupus erythematosus induced by anti-tumour necrosis factor alpha therapy: a French national survey.

    Michel De Bandt;Jean Sibilia;Xavier Le Loët;Sebastian Prouzeau

  • BONE MINERAL DENSITY IN MEN TREATED WITH SYNTHETIC GONADOTROPIN-RELEASING HORMONE AGONISTS FOR PROSTATIC CARCINOMA

    J.F. Maillefert;J. Sibilia;F. Michel;C. Saussine

  • Lymphomas in Patients With Sjögren's Syndrome Are Marginal Zone B-Cell Neoplasms, Arise in Diverse Extranodal and Nodal Sites, and Are Not Associated With Viruses

    Bruno Royer;Dominique Cazals-Hatem;Jean Sibilia;Felix Agbalika

  • Tolerance and efficacy of rituximab and changes in serum B cell biomarkers in patients with systemic complications of primary Sjögren’s syndrome

    Raphaèle Seror;Christelle Sordet;Loic Guillevin;Eric Hachulla

  • Outcomes of a multicentre randomised clinical trial of etanercept to treat ankylosing spondylitis

    A Calin;B A C Dijkmans;P Emery;M Hakala

  • Prognostic factors for radiographic damage in early rheumatoid arthritis: a multiparameter prospective study.

    B Combe;M Dougados;P Goupille;A Cantagrel

Frequent Co-Authors

Xavier Mariette
Xavier Mariette University of Paris-Saclay
Eric Hachulla
Eric Hachulla University of Lille
Maxime Dougados
Maxime Dougados Hôpital Cochin
Xavier Puéchal
Xavier Puéchal Université Paris Cité
Bernard Combe
Bernard Combe University of Montpellier
Philippe Ravaud
Philippe Ravaud Université Paris Cité
Luc Mouthon
Luc Mouthon Université Paris Cité
Alain Saraux
Alain Saraux University of Western Brittany
Bruno Fautrel
Bruno Fautrel Université Paris Cité
Yannick Allanore
Yannick Allanore Université Paris Cité

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Many students interested in studying Medicine in the USA explore alternative degrees and flexible career pathways in healthcare. Online nursing programs continue to rise in popularity due to their accessibility and affordability. For those seeking entry-level credentials, cheap online nursing programs allow aspiring nurses to earn their qualifications with less financial strain.

Registered nurses (RNs) looking to advance their careers often consider programs that lead to a Bachelor of Science in Nursing. If you’re researching, you may be asking, what is the cheapest rn to bsn program online to upgrade their credentials efficiently.

For those aiming to become nurse practitioners, affordability remains crucial. Understanding your options is key—explore the cheapest np programs online that offer flexibility while preparing you for advanced clinical roles.

Finally, nurses who wish to reach the highest academic and professional levels can pursue an advanced degree through online phd programs nursing. These online options make it easier than ever to achieve top qualifications and expand your career while balancing work and family commitments.

Best Scientists Citing Jean Sibilia

Trending Scientists

Recently Published Articles